Results 181 to 190 of about 14,247 (191)

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial

Human Vaccines and Immunotherapeutics, 2017
Olivier Godeaux, Martina Kovac, Katrijn Grupping   +2 more
exaly  

Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine

Vaccine, 2011
Hung Fu Tseng, Ning Smith, Lina S Sy
exaly  

Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review of Its Use in the Prevention of Herpes Zoster and Postherpetic Neuralgia in Adults Aged ≥50 Years

Drugs, 2013
exaly  

Herpes Zoster Vaccination

Giovanni Gabutti, Johan Flamaing
openaire   +1 more source

Effectiveness of the herpes zoster vaccine Zostavax

Vaccine, 2020
openaire   +2 more sources

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Journal of Infectious Diseases, 2018
Anthony L Cunningham, Thomas C Heineman, Olivier Godeaux   +2 more
exaly  

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

Vaccine, 2007
James M Pellissier, Marc Brisson, Myron J Levin   +2 more
exaly  

Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia

BioDrugs, 2016
exaly  

Herpes Zoster, Vaccine, and Stroke Risk

Clinical Infectious Diseases
Shih-Wei Lai, Sheng-Chun Chiu
openaire   +2 more sources

Postherpetic Neuralgia After Herpes Zoster Vaccination

JAMA, 2012
openaire   +5 more sources